2023
DOI: 10.1002/cam4.6206
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging characteristics of brain metastases in small cell lung cancer

Abstract: BackgroundLung is the most common primary site of brain metastases (BMs). For different pathological types of BMs have some similar characteristics, it is still a challenge to confirm the origin based on their characteristics directly. BMs of small cell lung cancer (SCLC) have favorable therapeutic expectations due to their high sensitivity to radiotherapy. This study sought to identify unique characteristics of BMs in SCLC, aiming to assist in clinical decision‐making.MethodsPatients diagnosed with BMs of lun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…According to the statistics, BM are a frequent complication in lung cancer patients, presenting in approximately 40% of patients with advanced adenocarcinoma and 50% with SCLC [15]. BM are present at diagnosis in approximately 18% of SCLC at initial diagnosis, and can reach 50-65% of cases within two years [16], moreover, the median survival of SCLC with BM is only 4.9 months [17]. The incidence of BM from breast cancer still following the lung cancer ranks second, accounting for about 10 to 30% [18], and with a median time of BM occurrence 2-3 years after the initial breast cancer diagnosis [19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the statistics, BM are a frequent complication in lung cancer patients, presenting in approximately 40% of patients with advanced adenocarcinoma and 50% with SCLC [15]. BM are present at diagnosis in approximately 18% of SCLC at initial diagnosis, and can reach 50-65% of cases within two years [16], moreover, the median survival of SCLC with BM is only 4.9 months [17]. The incidence of BM from breast cancer still following the lung cancer ranks second, accounting for about 10 to 30% [18], and with a median time of BM occurrence 2-3 years after the initial breast cancer diagnosis [19].…”
Section: Discussionmentioning
confidence: 99%
“…Currently, no clear and unified clinical treatment guideline for synchronous primary cancers has been developed [17]. Surgery remains the primary treatment option [24].…”
Section: Discussionmentioning
confidence: 99%